Skip to content

Intra-articular Pulsed Radiofrequency in Chronic Knee Pain

The Effectiveness of Intra-articular Pulsed Radiofrequency in Patients With Painful Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06017674
Enrollment
54
Registered
2023-08-30
Start date
2022-05-01
Completion date
2022-12-31
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee, Osteoarthritis, Pain, Chronic

Keywords

intra-articular pulsed radiofrequency, knee osteoarthritis, intra-articular steroid injection

Brief summary

The aim of this study is to investigate the additional effect of Intra-articular Pulsed Radiofrequency (IAPRF) on pain and functional activities in addition to intra-articular steroids in patients with grade II and III knee osteoarthritis.

Detailed description

This randomized controlled trial included patients over 18 years of age with knee pain persisting for more than 3 months and stage II-III knee OA according to the Kellgren-Lawrence scale. The participants were randomized into two groups: the IAPRF + steroid injection (Group 1) and only steroid injection (Group 2) groups. The injections were administered under fluoroscopic guidance in both groups, and the needle was advanced to the midline of the tibiofemoral joint in the anteroposterior and lateral views. Group 1 received 8 mg of intra-articular dexamethasone after IAPRF application for 360 s at 45 V voltage, with the temperature not exceeding 42°C. Group 2 received 8 mg of intra-articular dexamethasone only. Pain intensity and participation in daily activities were evaluated using the numerical rating scale (NRS) and Western Ontario and McMaster Universities arthritis index (WOMAC), respectively, before the procedure and 1, 4, and 12 weeks after the procedure.

Interventions

A 22-gauge 10 cm radiofrequency cannula with a 10-mm active tip was advanced to the mid-tibiofemoral joint under fluoroscopic guidance. After needle insertion, paresthesia-pain and motor stimulation tests were performed using sensory (50 Hz) and motor (2 Hz, 1 V) stimulation to confirm the absence of stimulation. Intra-articular Pulsed Radiofrequency (IAPRF) was applied at 45 V voltage for 20 ms pulse width for 360 s, followed by a 480 ms silent phase. The tissue temperature was adjusted to not exceed 42°C.

8 mg dexamethasone was applied into the tibio-femoral joint with a 22-gauge, 10 cm needle under fluoroscopy.

Sponsors

Başakşehir Çam & Sakura City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Procedures and evaluations were performed by different practitioners

Intervention model description

Single-center, single-blinded, randomized prospective trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years, * Having knee pain persisting for more than 3 months due to knee osteoarthritis (OA), * Kellgren-Lawrence Classification grades II and III OA, * Giving written and verbal informed consents.

Exclusion criteria

* Patients with a history of undergoing knee surgery and/or receiving any intra-articular knee injection within the previous 6 months, * Having a local or systemic infection or a coagulation disorder, * Patients who refused to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale0, 1, 4 and 12 weeksPain levels before and 1, 4, 12 weeks after the procedure were evaluated with Numeric Rating Scale (NRS). The patients were instructed to score their pain intensity on a scale of 0 to 10, where 0 represents no pain at all and 10 represents worst pain ever possible.

Secondary

MeasureTime frameDescription
Western Ontario and McMaster Universities Arthritis Index0, 1, 4 and 12 weeksThe Western Ontario and McMaster Universities Arthritis Index (WOMAC) was used to assess daily living activities at all evaluation points.The WOMAC consists of 24 items on three subscales: pain, stiffness, and physical function. All items were scored on a scale of 0 to 4, where 0 represents none, 1 represents mild, 2 represents moderate, 3 represents severe, and 4 represents extreme. The total score ranges from 0 to 96, with a higher score indicating poorer function in daily living activities.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026